Search

Your search keyword '"Chaudhry, Vinay"' showing total 303 results

Search Constraints

Start Over You searched for: Author "Chaudhry, Vinay" Remove constraint Author: "Chaudhry, Vinay"
303 results on '"Chaudhry, Vinay"'

Search Results

1. Epidemiological evidence for a hereditary contribution to myasthenia gravis: a retrospective cohort study of patients from North America

2. Assessing mNIS+7Ionis and international neurologists' proficiency in a familial amyloidotic polyneuropathy trial

3. Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

4. Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study

5. A Genome-Wide Association Study of Myasthenia Gravis

7. Implementing Motor Unit Number Index (MUNIX) in a large clinical trial: Real world experience from 27 centres

8. Proceedings of the 2023 Global Polytechnic Summit, Technology Talent: Advancing a Comprehensive and Global Strategy

9. A comprehensive study of skeletal muscle imaging in FHL1‐related reducing body myopathy

10. Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS

16. Improving the efficacy of exome sequencing at a quaternary care referral centre: novel mutations, clinical presentations and diagnostic challenges in rare neurogenetic diseases

18. Risk Factors for Infection and Health Impacts of the Coronavirus Disease 2019 (COVID-19) Pandemic in People With Autoimmune Diseases

20. RISK FACTORS FOR INFECTION AND HEALTH IMPACTS OF THE COVID-19 PANDEMIC IN PEOPLE WITH AUTOIMMUNE DISEASES

21. Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral Sclerosis

22. Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

25. Contributors

32. Contributors

34. Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study

36. Contributors

37. Risk Factors for Infection and Health Impacts of the Coronavirus Disease 2019 (COVID-19) Pandemic in People With Autoimmune Diseases.

40. Long-term safety and efficacy of eculizumab in generalized myasthenia gravis

44. Identification of Gulf War syndrome: methodological issues and medical illnesses

Catalog

Books, media, physical & digital resources